MedpageToday
20 articles in the TruthFoundry index. Each links out to the original.
- Microvascular Perfusion Predicts Stroke Outcomes Post Thrombectomy · Post-thrombectomy microvascular metrics predict poor stroke recovery better than standard measures.
- Trump Administration Distributes $90 Medicare Rebates Amid Midterm Criticism · President Trump's administration is issuing $90 one-time payments to eligible Medicare Part B enrollees, drawing criticism as an election-year political stunt.
- High Pulmonary Vascular Resistance Alone Should Not Disqualify Heart Transplant Candidates · Research suggests elevated PVR without high transpulmonary gradient should not rule out heart transplant candidates.
- Medical Podcast Reviews Septic Shock, Hormone Therapy, Liver Disease Studies · TTHealthWatch podcast discusses four recent clinical medical research topics.
- Nicotinamide Riboside Supplement Fails Parkinson's Phase III Trial · Popular longevity supplement nicotinamide riboside showed no benefit in early Parkinson's trial.
- Trump Health Officials Used Private Slack Chat For Tech AI Healthcare Lobbying · Trump administration health officials ran an unannounced Slack chat with tech leaders on healthcare AI policy.
- Registry Study Links LVADs to Strokes and Nonstroke Neurologic Events · A registry study found 8% stroke and 8% nonstroke neurologic event rates in HeartMate 3 LVAD recipients over 1.4 years.
- Oregon Leads U.S. Push for Single-Payer Healthcare System · Oregon aims to become the first U.S. state to implement a universal single-payer healthcare system by 2032.
- Trump Law Risks Removing Medicaid for Hundreds of Thousands of Legal Immigrants · New federal legislation threatens to strip Medicaid coverage from hundreds of thousands of lawfully present immigrants starting this month.
- RFK Jr. Claims AI Surpasses Doctors; PhRMA Elects Eric Cantor; MacArthur Grant Winners Announced · HHS Secretary RFK Jr. claims AI is better informed than doctors, while PhRMA selects Eric Cantor as its new leader.
- FDA Approves Tavapadon for Parkinson's Disease Treatment · The FDA approved AbbVie's tavapadon, the first D1/D5 dopamine agonist, for treating adults with Parkinson's disease.
- Trump and Kennedy's Health Industry Deals Are at Risk of Vanishing · Trump administration's voluntary health deals with food and insurers lack enforcement; promised changes on dyes and prior authorization remain unfulfilled.
- Mitch McConnell's Prolonged Health Silence Raises Recovery and Transparency Questions · Sen. Mitch McConnell has not shared a public health update since Aug. 6, 2026, after a fall and pneumonia, sparking expert and political calls for more transparency.
- Health Roundup: FDA Recalled Device Injuries, Military COVID Probe, Teen Vaccination Declines · MedPage Today's health roundup covers FDA device recall injuries, a military COVID vaccine investigation, and declining teen vaccination coverage.
- ESC Meeting Unveils STAREE Statin Trial and New Heart Attack Therapies · The ESC conference in Munich will present the STAREE trial results on statins for the elderly and updates on acute myocardial infarction therapies.
- Study Suggests Shingles Vaccine Reduces Heart Disease Risk · Observational study links recombinant shingles vaccine to lower cardiovascular event rates compared to the live vaccine.
- Medicare GLP-1 Discount Pilot Excludes Patients With Approved Medical Conditions · Medicare's $50 GLP-1 pilot excludes patients with conditions the drugs already treat.
- FDA Clears Roche and Lilly Blood Test for Alzheimer's Detection · FDA cleared the Elecsys pTau217 blood test to detect Alzheimer's pathology in patients 55 and older.
- Medicare Cuts Cataract Payments, Driving Patients to Pricier Laser Surgery · Medicare's declining reimbursement for cataract surgery is leading more patients to pay thousands out-of-pocket for laser-assisted procedures.
- Stopping Statins in Elderly Trial Shows No Mortality Increase · A randomized trial found stopping statins in patients over 75 did not raise mortality risk over three years.